| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1235.56 | 3% | $1.17T | 53.8 | 129% | 0.5% | Healthcare | 59.9% | 47.4% | ||
| 2 | Johnson & Johnson | $267.24 | 3.1% | $643.31B | 24.2 | -3.8% | 1.9% | Healthcare | 72.1% | 7.9% | ||
| 3 | AbbVie Inc. | $254.65 | -0% | $449.91B | 107.4 | -13.3% | 2.6% | Healthcare | 35.7% | 9.5% | ||
| 4 | UnitedHealth Group Incorporated | $428.19 | 2.4% | $388.86B | 32.4 | -44.6% | 2% | Healthcare | 41% | 9.7% | ||
| 5 | Merck & Co., Inc. | $128.86 | 1.6% | $318.26B | 17.7 | -48.3% | 2.5% | Healthcare | 59.3% | 2.5% | ||
| 6 | Novartis AG | $157.03 | 1% | $299.63B | 21.8 | 9.2% | 2.6% | Healthcare | 28.6% | 5.3% | ||
| 7 | AstraZeneca PLC | $193.12 | 1.6% | $299.39B | 29.5 | 33.1% | 1.7% | Healthcare | 35.4% | 9.9% | ||
| 8 | Novo Nordisk A/S | $49.64 | 0.8% | $220.59B | 14.1 | 16.8% | 3.6% | Healthcare | -28.4% | 8.1% | ||
| 9 | Amgen Inc. | $368.10 | 0.5% | $198.66B | 25.9 | 31.1% | 2.6% | Healthcare | 25.7% | 9.1% | ||
| 10 | Thermo Fisher Scientific Inc. | $516.62 | -0.2% | $191.99B | 29.1 | 6.7% | 0.3% | Healthcare | 23.4% | 5.4% | ||
| 11 | Gilead Sciences, Inc. | $136.36 | 5.2% | $169.3B | 20.1 | 54.5% | 2.3% | Healthcare | 22% | 3.5% | ||
| 12 | Abbott Laboratories | $95.84 | 0.2% | $166.94B | 25.8 | -53.4% | 2.5% | Healthcare | -28.3% | 6.6% | ||
| 13 | Intuitive Surgical, Inc. | $427.30 | -1.3% | $151.33B | 54.3 | 21% | — | Healthcare | -20.1% | 21.4% | ||
| 14 | Danaher Corporation | $194.19 | 0.3% | $137.44B | 38.5 | 0.4% | 0.6% | Healthcare | -2.7% | 4% | ||
| 15 | Pfizer Inc. | $24.07 | 1.5% | $136.92B | 17.7 | -5.1% | 7.1% | Healthcare | -4.6% | 1.4% | ||
| 16 | CVS Health Corporation | $104.33 | 2.2% | $133.12B | 75.1 | -45.8% | 2.6% | Healthcare | 56.5% | 7.6% | ||
| 17 | Vertex Pharmaceuticals Incorporated | $522.25 | -1.4% | $132.84B | 34.1 | 530.1% | — | Healthcare | 13.7% | 10.4% | ||
| 18 | Stryker Corporation | $313.38 | -0.5% | $120.14B | 37.3 | 16.8% | 1.1% | Healthcare | -20.2% | 8.8% | ||
| 19 | Bristol-Myers Squibb Company | $57.97 | 2.2% | $118.36B | 16.8 | 33.6% | 4.3% | Healthcare | 24.7% | 1.8% | ||
| 20 | Medtronic plc | $83.83 | 0.9% | $107.63B | 22.5 | 3% | 3.4% | Healthcare | -4.4% | 8.4% | ||
| 21 | GSK plc | $53.32 | 0.4% | $107.23B | 7.2 | 120.3% | 6.1% | Healthcare | 39.6% | 5.4% | ||
| 22 | Sanofi | $42.98 | 0.9% | $103.34B | 11.8 | 96.2% | 5.9% | Healthcare | -11.1% | 14.1% | ||
| 23 | McKesson Corporation | $807.33 | 2.9% | $97.04B | 21.0 | 49.1% | 0.4% | Healthcare | 9.8% | 12.4% | ||
| 24 | HCA Healthcare, Inc. | $423.11 | 1.4% | $93.86B | 14.9 | 29.2% | 0.7% | Healthcare | 11.6% | 6.7% | ||
| 25 | Elevance Health Inc. | $418.85 | 2.6% | $90.96B | 16.7 | -8.3% | 1.6% | Healthcare | 20.7% | 9.4% | ||
| 26 | Cigna Corporation | $286.62 | 1.6% | $75.57B | 12.9 | 30.6% | 2.1% | Healthcare | -8.6% | 8.8% | ||
| 27 | Regeneron Pharmaceuticals, Inc. | $676.23 | 4.1% | $70.26B | 16.3 | 4.5% | 0.5% | Healthcare | 25.7% | 5.9% | ||
| 28 | Boston Scientific Corporation | $45.30 | 1.6% | $67.33B | 23.4 | 74.4% | — | Healthcare | -56.4% | 17.4% | ||
| 29 | Cencora, Inc. | $304.48 | 2% | $59.24B | 38.3 | 51.3% | 0.7% | Healthcare | 0.7% | 5.9% | ||
| 30 | argenx SE | $919.94 | 0.3% | $56.93B | 46.9 | 279.7% | — | Healthcare | 68.5% | 174% | ||
| 31 | Becton, Dickinson and Company | $156.30 | 0.5% | $56.63B | 26.8 | -24.6% | 2.7% | Healthcare | 46.2% | 2.4% | ||
| 32 | Cardinal Health, Inc. | $239.71 | 0.9% | $56.41B | 37.2 | 2% | 0.9% | Healthcare | 43% | 12.8% | ||
| 33 | Edwards Lifesciences Corporation | $94.82 | -0.4% | $54.6B | 51.8 | -73.1% | — | Healthcare | 23.6% | 13.8% | ||
| 34 | Takeda Pharmaceutical Company Limited | $15.95 | -0.5% | $49.84B | 40.4 | 80.5% | 4% | Healthcare | 5.8% | -0.7% | ||
| 35 | Humana Inc. | $394.62 | 0.4% | $47.38B | 40.1 | -33.9% | 0.9% | Healthcare | 66.4% | 14.1% | ||
| 36 | IDEXX Laboratories, Inc. | $570.25 | 0.9% | $45.29B | 43.6 | 25.3% | — | Healthcare | 4.5% | 13.1% | ||
| 37 | Haleon plc | $9.84 | 1.2% | $43.82B | 20.4 | 53.3% | 1.8% | Healthcare | -3.1% | 10.7% | ||
| 38 | Alnylam Pharmaceuticals, Inc. | $321.59 | 2.7% | $42.91B | 138.0 | 301.4% | — | Healthcare | -0.8% | 82.6% | ||
| 39 | Revolution Medicines, Inc. | $190.46 | 0.2% | $40.49B | -32.0 | -77.3% | — | Healthcare | 419.4% | — | ||
| 40 | Natera, Inc. | $281.27 | -0.9% | $40.28B | -185.0 | -10.9% | — | Healthcare | 77.2% | 36.6% | ||